Loading...
Current Therapeutic Advances Targeting EGFR and EGFRvIII in Glioblastoma
Epidermal growth factor receptor (EGFR) and EGFRvIII analysis is of current interest in glioblastoma – the most common malignant primary CNS tumor, because of new EGFRvIII vaccine trials underway. EGFR activation in glioblastoma promotes cellular proliferation via activation of MAPK and PI3K–Akt pat...
Na minha lista:
| Udgivet i: | Front Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4310282/ https://ncbi.nlm.nih.gov/pubmed/25688333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|